The good part about Generex’s Triple negative study is it’s with the most prestigious group- NSABP Foundation. The main recruitment is at another most prestigious research spot the Cleveland Clinic. How they recruit now is difficult, but they are both top in class so leave that to them. Results will be far significant with NSABP since there is no organization with greater credibility. They halted in 2020 for safety obviously, now maybe not. It’s quite unusual for Generex to have formed a relationship with NSABP, usually that’s top pharma working with them. So whenever results come in, it will be far more credible and formidable with a top research professional from NSABP writing the report. Gold standard.